Vineet Laboratories Limited (NSE:VINEETLAB)
India flag India · Delayed Price · Currency is INR
32.91
-1.00 (-2.95%)
Jan 27, 2026, 3:29 PM IST

Vineet Laboratories Company Description

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India.

The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates.

It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde.

The company was incorporated in 2016 and is based in Hyderabad, India.

Vineet Laboratories Limited
CountryIndia
Founded2016
IndustryChemicals
SectorMaterials
Employees57
CEOGaddam Ramana

Contact Details

Address:
5-5-160, Malleswari Nilayam
Hyderabad, 500074
India
Phone91 40 2412 8833
Websitevineetlabs.co.in

Stock Details

Ticker SymbolVINEETLAB
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE505Y01010
SIC Code2833

Key Executives

NamePosition
Gaddam Venkata RamanaFounder, MD and Director
Satyanarayana Raju BhupathirajuChief Financial Officer and Whole-time Director
B V RamakrishnaSenior Manager of Finance and Accounts
Rameshkumar BandariCompany Secretary and Compliance Officer
Pavani Srinivasa RaoManager of Human Resources